title: Axonal degeneration in systemic sclerosis can be reverted by factors improving tissue oxygenation.
authors.forename: V
authors.initials: V
authors.lastname: Provitera
authors.forename: M
authors.initials: M
authors.lastname: Nolano
authors.forename: N
authors.initials: N
authors.lastname: Pappone
authors.forename: E
authors.initials: E
authors.lastname: Lubrano
authors.forename: A
authors.initials: A
authors.lastname: Stancanelli
authors.forename: B
authors.initials: B
authors.lastname: Lanzillo
authors.forename: L
authors.initials: L
authors.lastname: Santoro
mesh_terms: D000328:Adult; D000368:Aged; D001369:Axons / Q000473:pathology*; D005260:Female; D006801:Humans; D016285:Iloprost / Q000627:therapeutic use; D008875:Middle Aged; D009410:Nerve Degeneration / Q000188:drug therapy*; D010101:Oxygen Consumption; D012595:Scleroderma, Systemic / Q000150:complications*; D012867:Skin / Q000294:innervation*; D014665:Vasodilator Agents / Q000627:therapeutic use*
chemical_list: D014665:Vasodilator Agents; D016285:Iloprost